Table 2

Serious adverse events: SHIELD study

Type of eventWHO grade 1 or 2WHO grade 3 or 4Comments
Infective    
    Neutropenic sepsis, organ not specified 16 3 fatal 
    Infective, organ specified  
    Pyrexia unknown, origin presumed infective (not neutropenic) 11  
Hematologic 13 Neutropenia (12), neutropenia and thrombocytopenia (2), anemia (3) 
Cardiovascular DVT (2), myocardial infarct (2, one fatal), arrhythmia (1), chest pain (2), sudden death presumed cardiac (1) 
Nervous system Stroke (2, one fatal), motor weakness (1), epilepsy (1) 
Pulmonary (noninfective) Pulmonary fibrosis (bleomycin) (1), SOB, ? cause (1) 
Gastrointestinal  
Renal Hydronephrosis 
Bone  
Cancer AML (1), rectal cancer (1), carcinoid (1); 3 cancers reported as SAE, others discussed in text occurred in follow-up period 
Metabolic Hyponatremia 
ENT Tinnitus 
Total 48 49  
Type of eventWHO grade 1 or 2WHO grade 3 or 4Comments
Infective    
    Neutropenic sepsis, organ not specified 16 3 fatal 
    Infective, organ specified  
    Pyrexia unknown, origin presumed infective (not neutropenic) 11  
Hematologic 13 Neutropenia (12), neutropenia and thrombocytopenia (2), anemia (3) 
Cardiovascular DVT (2), myocardial infarct (2, one fatal), arrhythmia (1), chest pain (2), sudden death presumed cardiac (1) 
Nervous system Stroke (2, one fatal), motor weakness (1), epilepsy (1) 
Pulmonary (noninfective) Pulmonary fibrosis (bleomycin) (1), SOB, ? cause (1) 
Gastrointestinal  
Renal Hydronephrosis 
Bone  
Cancer AML (1), rectal cancer (1), carcinoid (1); 3 cancers reported as SAE, others discussed in text occurred in follow-up period 
Metabolic Hyponatremia 
ENT Tinnitus 
Total 48 49  

DVT indicates deep vein thrombosis; SOB, shortness of breath; and AML, acute myeloid leukemia.

or Create an Account

Close Modal
Close Modal